fanfan Wang

Ms. fanfan Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YFYanyan Fang
Yanyan Fang
JLJian Liu
Jian Liu
LXLing Xin
Ling Xin
HJHui Jiang
Hui Jiang
JWJianting Wen
Jianting Wen
QHQi Han
Qi Han

4 December 2023 in ACS Omega
Verified
Journal Article
Open access
FWfanfan Wang
fanfan Wang
JLJian Liu
Jian Liu
YFYanyan Fang
Yanyan Fang
JWJianting Wen
Jianting Wen
MHMingyu He
Mingyu He
XLXu Li
Xu Li
Background: Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic systemic inflammation, leading to joint deformities and functional loss. RA progression is accompanied by abnormalities in the coagulation-fibrinolysis system, clinically manifested as a hypercoagulable state. However, there are currently no bibliometrics or visualization analysis in this field. Objective: The present study aims to reveal the knowledge structure, research status, and research trends related to hypercoagulability in RA through bibliometric analysis and to evaluate the utility of inflammatory and coagulation markers in RA disease activity through retrospective data mining. Methods: English articles and reviews on RA hypercoagulability published from 2010 to 2023 were extracted from the Web of Science Core Collection (WoSCC) database on March 1, 2023. VOSviewer and CiteSpace software were used for knowledge mapping analysis of the included papers in terms of countries/regions, institutions, journals, authors, keywords, research hotspots, and frontiers. A retrospective analysis was conducted on the general information on RA patients. The demographic and clinical indicators of all participants were collected to determine the correlation of inflammatory and coagulation markers with the Chinese patient-reported activity index for rheumatoid arthritis (CPRI-RA). Results: A total of 957 papers were retrieved. The United States was the most productive country in this field and had the highest h-index, and the most prolific institution was the Karolinska Institute. The Annals of the Rheumatic Diseases was the journal with the most publications, and KLARESKOG L. was the most productive author. From keyword analysis, it could be seen that "inflammation", "activation", "disease-activity", and "risk" had long been the focuses of RA hypercoagulability research. "Criteria", "validation", "coagulation", "target", and "anemia" were the latest popular keywords in the past 5 years. Retrospective data mining revealed that the levels of inflammation (RF, ESR, and CRP) and coagulation (PLT and DD) were significantly increased in RA patients. FBG, CRP, and ESR were significantly correlated with CPRI-RA. Additionally, ESR, CRP, and FBG were identified as independent risk factors for CPRI-RA. Conclusion: The mechanism and application of hypercoagulability in RA have been research hotspots in recent years. Inflammation and coagulation markers are independent risk factors for CPRI-RA.

19 September 2025 in Medicine
Verified
Journal Article
Open access
YLYang Li
Yang Li
JLJian Liu
Jian Liu
YHYuedi Hu
Yuedi Hu
CCCheng-zhi Cong
Cheng-zhi Cong
YCYiming Chen
Yiming Chen
FWfanfan Wang
fanfan Wang
The aim of this study was to elucidate the research direction and application value of neutrophil-to-lymphocyte ratio (NLR) as an emerging inflammatory marker in rheumatoid arthritis (RA) from both literature and clinical perspectives. Firstly, we made an extensive analysis in terms of the number of publications, highly cited literature, co-cited references, and keywords. Subsequently, a retrospective exploration of clinical data of 1490 patients with rheumatic diseases admitted to the First Affiliated Hospital of Anhui University of Chinese Medicine was conducted. Logistic regression models were used to explore the independent predictive role of NLR in different scenarios. Nomogram was developed and the model was clinically evaluated by recipient operating characteristic (ROC) curves, calibration plots and decision curve analysis. In addition, association rule analysis and Mantel test were used to determine associations between NLR and clinical characteristics and self-perception of patients. A total of 544 articles were retrieved, focusing on the pathophysiology and clinical studies of RA-NLR, such as “disease activity,” “inflammation” and “classification.” Retrospective analysis demonstrated that NLR, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were significantly higher in RA patients than in non-RA patients. Logistic regression models identified gender, age, NLR, ESR and CRP as independent predictors of RA. The ROC curve determined a cutoff value of 2.258 for NLR and a maximum area under the curve of 0.736. Both association rule analysis and Mantel test showed that NLR was highly correlated with inflammatory markers such as ESR, CRP, and self-perception scale scores before and after treatment. NLR > 2.258 was a meaningful risk factor for moderate-to-severe pain and higher disease activity, which predictive reliability was further confirmed in subgroup stratification analyses. NLR, as a novel inflammatory marker, correlates with clinical characteristics and self-perception of RA patients, acting as an independent predictor of RA diagnosis and activity assessment.

13 September 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YFYanyan Fang
Yanyan Fang
JLJian Liu
Jian Liu
LXLing Xin
Ling Xin
HJHui Jiang
Hui Jiang
JGJinchen Guo
Jinchen Guo
DHDan Huang
Dan Huang
Radix Salvia miltiorrhiza (RSM) is widely used for the clinical improvement of inflammatory diseases. However, the actions of RSM in the treatment of ankylosing spondylitis (AS) have not been fully explored. Therefore, this study was designed to use retrospective clinical data mining approach to understand the effects of RSM on AS‐related immuno‐inflammatory processes, use network pharmacology to predict therapeutic targets of RSM, and to further investigate the pharmacological molecular mechanism in vitro. RSM treatment has a long‐term correlation with the improvement of AS‐related immuno‐inflammatory indicators through computational models. We established protein‐protein interaction networks, conducted KEGG analysis to enrich significant TNF pathways, and finally obtained three core targets of RSM in the treatment of AS, namely, prostaglandin endoperoxide synthase 2 (PTGS2), interleukin‐6 (IL‐6), and tumor necrosis factor‐alpha (TNF‐alpha). Screening of RSM active ingredients with node degree greater than 20 yielded cryptotanshinone and tanshinone IIA, and previous studies have reported their anti‐inflammatory effects. In vitro, both cryptotanshinone and tanshinone IIA significantly inhibited the expressions of PTGS2, IL‐6, and TNF‐α in peripheral blood mononuclear cells in AS patients. In conclusion, cryptotanshinone and tanshinone IIA, which are the active components of RSM, may inhibit the activation of TNF signaling pathway in AS patients by downregulating the expression of PTGS2, IL‐6, and TNF‐α. These findings illustrate that RSM may be a promising therapeutic candidate for AS, but further validation is required.

1 January 2023 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YFYanyan Fang
Yanyan Fang
JLJian Liu
Jian Liu
LXLing Xin
Ling Xin
XCXiaolu Chen
Xiaolu Chen
XDXiang Ding
Xiang Ding
JZJunru Zhang
Junru Zhang
Objective. To evaluate whether traditional Chinese medicine compound preparations (TCMCPs) are associated with rheumatoid arthritis‐ (RA‐) related complications (including readmission, Sjogren’s syndrome, surgical treatment, and all‐cause death) in patients with RA. Methods. Clinical outcome data were retrospectively collected from patients with RA discharged from the Department of Rheumatology and Immunology of the First Affiliated Hospital of Anhui University of Chinese Medicine from January 2009 to June 2021. The propensity score matching method was used to match baseline data. Multivariate analysis was conducted to analyze sex, age, the incidence of hypertension, diabetes, and hyperlipidemia and identify the risk of readmission, Sjogren’s syndrome, surgical treatment, and all‐cause death. Users of TCMCP and nonusers of TCMCP were defined as the TCMCP and non‐TCMCP groups, respectively. Results. A total of 11,074 patients with RA were included in the study. The median follow‐up time was 54.85 months. After propensity score matching, the baseline data of TCMCP users corresponded with those of non‐TCMCP users, with 3517 cases in each group. Retrospective analysis revealed that TCMCP significantly reduced clinical, immune, and inflammatory indices in patients with RA, and these indices were highly correlated. Notably, the composite endpoint prognosis for treatment failure in TCMCP users was better than that in non‐TCMCP users (HR = 0.75 (0.71‐0.80)). The risk of RA‐related complications in TCMCP users with high‐exposure intensity (HR = 0.669 (0.650‐0.751)) and medium‐exposure intensity (HR = 0.796 (0.691‐0.918)) was significantly lower than those in non‐TCMCP users. An increase in exposure intensity was associated with a concomitant decrease in the risk of RA‐related complications. Conclusion. The use of TCMCPs, as well as long‐term exposure to TCMCPs, may lower RA‐related complications, including readmission, Sjogren’s syndrome, surgical treatment, and all‐cause death, in patients with RA.